2m 2m 2m 2m 2m 2m 2m
KALARIS THERAP (KLRS)
NASDAQ
$4.74+$0.02 (+0.42%)
Price as of Jun 03, 2026 6:19 PM EDT- $125.4MMarket Cap
- 50.97%1-Year Change
- BiotechnologyIndustry
KALARIS THERAP (KLRS)
$4.74+$0.02 (+0.42%)
KLRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.72 | ||
Change | -$0.25 (-5.10%) | ||
Open | $4.66 | ||
High | $4.97 | ||
Low | $4.66 | ||
Previous Close | $4.65 | ||
Volume | 45,596 | ||
30-Day Average Volume | 91,920 | ||
1-Week Change | -10.75% | ||
1-Month Change | -14.84% | ||
1-Year Change | 50.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.8M | ||
Total Assets | $109.8M | ||
Market Cap | $125.4M | ||
Enterprise Value | $91.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.9M | ||
Free Cash Flow | -$11.6M | ||
EBIT | -$10.9M | ||
EBITDA | -$10.8M | ||
Net Working Capital | $90.4M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue